3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
6
Leukemia, Myelomonocytic, Chronic
3
Neoplasms
2
Myeloproliferative Disorders
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Nuclear Medicine Department, Hospital
4
Cyclophosphamide
4
fludarabine
3
Specimen Handling
3
Gemcitabine
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Eflornithine
2
Cisplatin
2
tazemetostat
1
talazoparib
1
selinexor
1
pazopanib
1
palbociclib
1
mifamurtide
1
merphos
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Azacitidine
×
30 days
×
Clear all
No trials found.